Cencora EPS - Earnings per Share 2010-2025 | COR
Cencora annual and quarterly earnings per share history from 2010 to 2025. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- Cencora EPS for the quarter ending March 31, 2025 was $3.68, a 76.08% increase year-over-year.
- Cencora EPS for the twelve months ending March 31, 2025 was $8.64, a 5.47% decline year-over-year.
- Cencora 2024 annual EPS was $7.53, a 11.72% decline from 2023.
- Cencora 2023 annual EPS was $8.53, a 6.09% increase from 2022.
- Cencora 2022 annual EPS was $8.04, a 8.8% increase from 2021.
| Cencora Annual EPS | |
|---|---|
| 2024 | $7.53 |
| 2023 | $8.53 |
| 2022 | $8.04 |
| 2021 | $7.39 |
| 2020 | $-16.65 |
| 2019 | $4.04 |
| 2018 | $7.53 |
| 2017 | $1.64 |
| 2016 | $6.32 |
| 2015 | $-0.63 |
| 2014 | $1.16 |
| 2013 | $1.84 |
| 2012 | $2.80 |
| 2011 | $2.54 |
| 2010 | $2.22 |
| 2009 | $1.66 |
| Cencora Quarterly EPS | |
|---|---|
| 2025-03-31 | $3.68 |
| 2024-12-31 | $2.50 |
| 2024-09-30 | $0.04 |
| 2024-06-30 | $2.42 |
| 2024-03-31 | $2.09 |
| 2023-12-31 | $2.98 |
| 2023-09-30 | $1.72 |
| 2023-06-30 | $2.35 |
| 2023-03-31 | $2.13 |
| 2022-12-31 | $2.33 |
| 2022-09-30 | $1.40 |
| 2022-06-30 | $1.92 |
| 2022-03-31 | $2.59 |
| 2021-12-31 | $2.13 |
| 2021-09-30 | $2.08 |
| 2021-06-30 | $1.40 |
| 2021-03-31 | $2.10 |
| 2020-12-31 | $1.81 |
| 2020-09-30 | $-23.60 |
| 2020-06-30 | $1.41 |
| 2020-03-31 | $4.64 |
| 2019-12-31 | $0.90 |
| 2019-09-30 | $0.64 |
| 2019-06-30 | $1.43 |
| 2019-03-31 | $0.13 |
| 2018-12-31 | $1.84 |
| 2018-09-30 | $1.09 |
| 2018-06-30 | $1.25 |
| 2018-03-31 | $1.29 |
| 2017-12-31 | $3.90 |
| 2017-09-30 | $-1.56 |
| 2017-06-30 | $0.23 |
| 2017-03-31 | $1.86 |
| 2016-12-31 | $1.11 |
| 2016-09-30 | $0.64 |
| 2016-06-30 | $1.55 |
| 2016-03-31 | $2.68 |
| 2015-12-31 | $1.45 |
| 2015-09-30 | $1.72 |
| 2015-06-30 | $0.89 |
| 2015-03-31 | $-2.33 |
| 2014-12-31 | $-0.91 |
| 2014-09-30 | $0.29 |
| 2014-06-30 | $-0.06 |
| 2014-03-31 | $0.76 |
| 2013-12-31 | $0.17 |
| 2013-09-30 | $0.23 |
| 2013-06-30 | $0.71 |
| 2013-03-31 | $0.19 |
| 2012-12-31 | $0.71 |
| 2012-09-30 | $0.66 |
| 2012-06-30 | $0.71 |
| 2012-03-31 | $0.81 |
| 2011-12-31 | $0.62 |
| 2011-09-30 | $0.54 |
| 2011-06-30 | $0.66 |
| 2011-03-31 | $0.77 |
| 2010-12-31 | $0.57 |
| 2010-09-30 | $0.50 |
| 2010-06-30 | $0.57 |
| 2010-03-31 | $0.63 |
| 2009-12-31 | $0.52 |
| 2009-09-30 | $0.43 |
| 2009-06-30 | $0.40 |
| 2009-03-31 | $0.47 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $57.517B | $293.959B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $139.155B | 26.10 |
| Elevance Health (ELV) | United States | $84.931B | 10.96 |
| CVS Health (CVS) | United States | $84.554B | 10.51 |
| Natera (NTRA) | United States | $23.347B | 0.00 |
| DiDi Global (DIDIY) | China | $22.403B | 23.80 |
| Labcorp Holdings (LH) | United States | $21.878B | 17.75 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.676B | 0.00 |
| Solventum (SOLV) | United States | $12.566B | 13.30 |
| CochLear (CHEOY) | Australia | $12.083B | 0.00 |
| ICON (ICLR) | Ireland | $11.595B | 10.78 |
| Revvity (RVTY) | United States | $11.128B | 19.15 |
| Doximity (DOCS) | United States | $10.714B | 49.60 |
| Viatris (VTRS) | United States | $10.293B | 3.54 |
| Avantor (AVTR) | United States | $9.056B | 13.16 |
| HealthEquity (HQY) | United States | $8.820B | 38.64 |
| Medpace Holdings (MEDP) | United States | $8.700B | 23.11 |
| Sonic Healthcare (SKHHY) | Australia | $8.407B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.136B | 13.98 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.085B | 24.06 |
| BrightSpring Health Services (BTSG) | United States | $3.934B | 36.10 |
| Sotera Health (SHC) | United States | $3.105B | 17.65 |
| Alignment Healthcare (ALHC) | United States | $2.849B | 0.00 |
| Concentras Parent (CON) | United States | $2.676B | 15.47 |
| Organon (OGN) | United States | $2.568B | 2.73 |
| Surgery Partners (SGRY) | United States | $2.542B | 33.06 |
| PACS (PACS) | United States | $2.027B | 0.00 |
| Progyny (PGNY) | United States | $1.856B | 40.85 |
| Ardent Health (ARDT) | United States | $1.854B | 7.90 |
| GeneDx Holdings (WGS) | United States | $1.838B | 70.80 |
| Premier (PINC) | United States | $1.834B | 13.92 |
| GoodRx Holdings (GDRX) | United States | $1.600B | 32.00 |
| Teladoc Health (TDOC) | United States | $1.230B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.147B | 8.73 |
| Establishment Labs Holdings (ESTA) | $1.100B | 0.00 | |
| CareDx (CDNA) | United States | $1.060B | 16.55 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Agilon Health (AGL) | United States | $0.902B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.856B | 8.01 |
| QDM (QDMI) | Hong Kong, SAR China | $0.758B | 0.00 |
| LifeMD (LFMD) | United States | $0.684B | 0.00 |
| Nutex Health (NUTX) | United States | $0.661B | 10.01 |
| Embecta (EMBC) | United States | $0.569B | 3.83 |
| InnovAge Holding (INNV) | United States | $0.512B | 0.00 |
| SBC Medicals (SBC) | United States | $0.482B | 0.00 |
| Enhabit (EHAB) | United States | $0.473B | 38.92 |
| Auna S.A (AUNA) | Luxembourg | $0.459B | 10.33 |
| Sonida Senior Living (SNDA) | United States | $0.454B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.449B | 0.00 |
| Omada Health (OMDA) | $0.399B | 0.00 | |
| Performant Healthcare (PHLT) | United States | $0.267B | 0.00 |
| Oncology Institute (TOI) | United States | $0.212B | 0.00 |
| Beauty Health (SKIN) | United States | $0.184B | 0.00 |
| DocGo (DCGO) | United States | $0.165B | 27.00 |
| Pheton Holdings (PTHL) | China | $0.119B | 0.00 |
| So-Young (SY) | China | $0.102B | 0.00 |
| KindlyMD (NAKA) | United States | $0.084B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.071B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.053B | 0.00 |
| ModivCare (MODV) | United States | $0.052B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.049B | 0.00 |
| Biodesix (BDSX) | United States | $0.040B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.034B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |